Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTITUMOR AGENT
Document Type and Number:
WIPO Patent Application WO/2021/210343
Kind Code:
A1
Abstract:
The present invention makes it possible to provide an antitumor agent capable of suppressing the proliferation of cancer cells without affecting normal cells. Use is made of an antitumor agent that comprises a substance inhibiting the binding between CSN5 and CDK2.

Inventors:
KATO JUNYA (JP)
Application Number:
PCT/JP2021/011366
Publication Date:
October 21, 2021
Filing Date:
March 19, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NATIONAL UNIV CORPORATION NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP)
International Classes:
A61K48/00; A61K35/76; A61K38/10; A61K38/16; A61P35/00; A61P43/00; C07K14/00; C12N15/11; C12N15/85
Other References:
KATO, JUNYA ET AL.: "CDK2-CSN5 complex is a novel target for cancer suppression", MY ABSTRACT OF THE 75TH ANNUAL MEETING OF THE JAPANESE CANCER ASSOCIATION, 2016, pages 643
Attorney, Agent or Firm:
HARAKENZO WORLD PATENT & TRADEMARK (JP)
Download PDF: